Life ScienceCompany
Mayne Pharma Group M&A Summary
Mayne Pharma Group has acquired 4 companies. It has also divested 2 assets.
Mayne Pharma Group’s largest acquisition to date was in 2012, when it acquired Metrics for $120M. It’s largest disclosed sale occurred in 2022, when it sold Metrics Contract Services to Catalent for $475M. Mayne Pharma Group has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).
Mayne Pharma Group Business Overview
Where is Mayne Pharma Group headquartered?
Mayne Pharma Group is headquartered in Salisbury South, Australia.
What sector is Mayne Pharma Group in?
Mayne Pharma Group is a life science company.
M&A Summary
-
M&A Total Activity6
- M&A Buy Activity4
- M&A Sell Activity2
- Total Sectors Invested 1
- Total Countries Invested 2
- M&A Buy/Sell Connections 3